Sep 29, 2021 / 12:40PM GMT
Charles Cliff Duncan - Cantor Fitzgerald & Co., Research Division - Senior Analyst
Hello. Good morning, and welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a Managing Director and Senior Biotechnology Analyst with the firm's equity research department.
And today is day 3 of the annual conference. And I have to say, wow, what a year it has been since we've last hosted our clients in the fall of 2020.
So it's a pleasure to introduce the next presenting company that is Novavax. And with me today, I have Greg Glenn, the Chief Guru or Vaccine Guru, actually the Vice President of R&D. Greg, good morning. Good to see you.
Gregory M. Glenn - Novavax, Inc. - President of Research & Development
Good morning, Charles.
Charles Cliff Duncan - Cantor Fitzgerald & Co., Research Division - Senior Analyst
And I also have John Trizzino, the company's Chief Commercial Officer, who actually used to be the Chief Financial Officer as well. John, nice to see you.
Novavax Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers